Allergy Therapeutics competitors

Allergy Therapeutics Competitors include STERIS, BioScrip, Cytokinetics and Horizon Pharma.
Add company...
Allergy Therapeutics
Allergy Therapeutics
Allergy Therapeutics (AT) is a European-based speciality pharmaceutical company focused upon the treatment and prevention of allergy.
STERIS
STERIS
STERIS Corporation offers customized infection prevention and contamination control solutions for a variety of environments.
BioScrip
BioScrip
We are a national post-acute solutions provider with over 30 years of experience.
Cytokinetics
Cytokinetics
We are focused on discovering and developing muscle activators as drug candidates for debilitating diseases.
Horizon Pharma
Horizon Pharma
Horizon Pharma plc (NASDAQ:HZNP) is a biopharmaceutical company with corporate and EU headquarters in Dublin, Ireland and U.S. headquarters in Lake Forest, IL
Founding Date
Founding Date
1934
Founding Date
1987
Founding Date
N/A
Founding Date
1997
Founding Date
2008
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Worthing, GB HQ
Locations
Mentor, US HQ
Mentor, US
Locations
Denver, US HQ
Elmsford, US
Eden Prairie, US
Locations
South San Francisco, US HQ
Locations
Ballsbridge, IE HQ
Mannheim, DE
Reinach, CH
Roswell, US
Lake Forest, US
Chicago, US
Employees
Employees
50615% increase
Employees
12,000
Employees
1,72715% decrease
Employees
1378% increase
Employees
9359% decrease
Valuation ($)
Valuation ($)
268.2 m
Valuation ($)
10.1 b
Valuation ($)
495.5 m
Valuation ($)
413.6 m
Valuation ($)
3.4 b
Twitter followers
Twitter followers
N/A
Twitter followers
2.7 k
Twitter followers
291
Twitter followers
680
Twitter followers
2 k

Financial

Revenue (est.)
Revenue (est.)
£64.1m (FY, 2017)
Revenue (est.)
$2.6b (FY, 2018)
Revenue (est.)
$817.2m (FY, 2017)
Revenue (est.)
$13.4m (FY, 2017)
Revenue (est.)
$1.1b (FY, 2017)
Cost of goods
Cost of goods
£16.8m (FY, 2017)
Cost of goods
$1.5b (FY, 2018)
Cost of goods
$547.9m (FY, 2017)
Cost of goods
N/A
Cost of goods
$546.3m (FY, 2017)
Gross profit
Gross profit
£47.4m (FY, 2017)
Gross profit
$1.1b (FY, 2018)
Gross profit
$269.2m (FY, 2017)
Gross profit
N/A
Gross profit
$510m (FY, 2017)
Net income
Net income
(£2.5m) (FY, 2017)
Net income
$290.9m (FY, 2018)
Net income
($64.2m) (FY, 2017)
Net income
($127.8m) (FY, 2017)
Net income
($410.5m) (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 109.5m
Total funding raised
N/A
Total funding raised
$ 63m
For sources of this data, please see the company profileDownload Excel

View company profiles

STERIS
HQ
Mentor, US
Employees
12,000

STERIS Corporation offers customized infection prevention and contamination control solutions for a variety of environments.

View company
BioScrip
HQ
Denver, US
Employees
1,727↓ 15% decrease

We are a national post-acute solutions provider with over 30 years of experience.

View company
Cytokinetics
HQ
South San Francisco, US
Employees
137↑ 8% increase

We are focused on discovering and developing muscle activators as drug candidates for debilitating diseases.

View company
Horizon Pharma
HQ
Ballsbridge, IE
Employees
935↓ 9% decrease

Horizon Pharma plc (NASDAQ:HZNP) is a biopharmaceutical company with corporate and EU headquarters in Dublin, Ireland and U.S. headquarters in Lake Forest, IL

View company